Navigation Links
The New Crystalens HD Gives Many Baby Boomers and Seniors an Opportunity to See Clearly at All Distances while Reducing or Eliminating the Need for Glasses
Date:2/7/2009

Updegraff Vision Precision LASIK™ and Cataract Center announces the addition of the Crystalens HD to their existing portfolio of high technology lens implants. The Crystalens offered by Dr. Updegraff is helping the +50 consumer understand that they can do something about their cataracts and their glasses with one surgery.

(Vocus) February 7, 2009 -- Dr. Stephen Updegraff, St. Petersburg and Tampa, FL offers his patients the Crystalens HD. The Crystalens HD is an accommodating intraocular lens that, unlike a standard Intraocular Lens ( IOL), can treat both a person's cataracts and presbyopia--loss of near and intermediate vision. Unlike the standard cataract replacement lenses, Crystalens not only eliminates the patient's cataract but can also give the patient a full range of vision so that the patient can potentially see near, far and everything in between. The Crystalens HD is an "advanced generation lens" meaning it is an enhanced version of the highly successful Crystalens design. Crystalens, which is a product of Bausch & Lomb, is the only FDA approved accommodating intraocular lens and the only intraocular lens that uses the natural focusing ability of the eye by using the eye muscle to flex and accommodate.

Most people start to notice in their forties the loss of some up-close vision and as a result had to start wearing reading glasses. Crystalens not only treats cataracts (a clouding or hardening of the eye's natural lens), but can also reduce or eliminate dependence on glasses. It does so by recreating accommodation similar to your eye's natural lens. The unique Crystalens can oftentimes reduce the need for glasses for most activities, including: reading a book, working on the computer, and driving a car.

A cataract is a clouding of the eye's natural lens resulting in distorted and fuzzy vision. Crystalens HD replaces the eye's natural lens with one that allows for improved vision near, far and in between and permanently removes the patient's cataract. "If you are planning to have cataract surgery, you should know about the Crystalens HD," Updegraff said. Dr. Updegraff has been performing cataract and lens implant surgery for more than a decade and was one of the first surgeons in the nation to use the first generation Crystalens starting in 2003.

Crystalens was modeled after the human eye. Like the natural lens, it uses the eye muscle to flex and accommodate in order to focus on objects in the environment at all distances. Crystalens dynamically adjusts to your visual needs. For additional information on the life changing, lifestyle lens, Crystalens, contact Updegraff Vision Precision LASIK™ and Cataract Center at 888-USA-2015 (888-872-2015) or request information through our contact form.

###

Read the full story at http://www.prweb.com/releases/crystalens/cataracts/prweb1970564.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Bausch & Lombs Crystalens to be Featured in Florida Advertising Campaign.
2. Crystalens HD(TM) Receives FDA Approval
3. UDM School of Dentistry Gives Kids A Smile
4. 7UP Gives Consumers a New Reason to Fall in Love - New Cherry 7UP Antioxidant
5. President Obama Gives the Unborn at Least a 24 Hour Reprieve, Postpones $441 Million Bailout of International Abortions, Says Family Research Council
6. Former Johnson & Johnson Executive Gives Big Voice to Small Companies
7. Growth in the Functional Food Sector Gives a Hearty Boost to the Heart Health Ingredients Market
8. CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back
9. Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
10. NASDAQ Gives Dynatronics a Second Three-Month Extension for Minimum Bid Price Compliance
11. Sandias microencapsulation project gives local entrepreneur warm glow
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The New Crystalens HD Gives Many Baby Boomers and Seniors an Opportunity to See Clearly at All Distances while Reducing or Eliminating the Need for Glasses
(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016  SI-BONE, Inc., a medical device company that ... a minimally invasive surgical (MIS) device indicated for fusion for certain ... Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states of ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: